Table 3. List of Interview Topics^a .

Implementers/Regulators	Private Stakeholders/Actors
1. Views on the problem of inappropriate use of TB medicines	1. Role of firm/organization in production/distribution/provision of TB medicines
2.Policy or institutional stance on the problem	2. Experiences of participating in these activities
3. Formal regulatory functions of institution	3. Provisions for quality control in areas of work
4. Actual role of the institution vis-a-vis regulation of TB medicines – in detail	4. Organizational stance vis-a-vis regulation of relevant activities
5. Experiences of actual institutional processes relating to regulation of TB medicines	5. Views on the need for greater regulation of relevant activities
6. Experiences of actual institutional processes relating to partnership with private providers, where relevant	6. Experiences of encountering regulatory processes if any – in detail
7. Role conflicts and overlaps with other institutions, if any	7. Experience of partnership with government TB programme (if relevant)
8. Obstacles and concerns vis-a-vis the issue of regulation of TB medicines	8. Key obstacles and concerns vis-a-vis the issue of regulation of TB medicines
9. Opportunities for partnership with private sector, and for strengthening regulatory processes	9. Key opportunities for partnerships and for quality enhancement
10. Avenues for institutional development and areas of improvement or new work	10. Organizational ambitions and plans for future work

Abbreviation‏: TB, tuberculosis.

^a Full topic guides are available on request.